Fatma A.F. Ragab
Fatma A.F. Ragab publishes mostly in Organic Chemistry, Molecular Biology and Toxicology, on topics such as Synthesis and biological activity, Synthesis and Biological Evaluation and Bioactive Compounds and Antitumor Agents.
- World rank
- #1,562,316 of 7,710,434 ranked researchers
- Rank in Egypt
- #4,012 of 36,277
- Works
- 24
- Citations
- 769
- Citations per work
- 32.0
What does Fatma A.F. Ragab research?
Fatma A.F. Ragab's work is mostly in Chemistry (62%), Biochemistry, Genetics and Molecular Biology (25%), Pharmacology, Toxicology and Pharmaceutics (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences1561.7%
- Chemistry1561.7%
- Life Sciences730.0%
- Health Sciences15.0%
- Medicine15.0%
- Everything else13.3%
- 1Organic Chemistry60% of their works
- 2Molecular Biology23% of their works
- 3Toxicology5% of their works
- 4Pathology and Forensic Medicine5% of their works
- 5Cell Biology2% of their works
- 6Inorganic Chemistry2% of their works
Research topics
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Bioactive Compounds and Antitumor Agents
- Synthesis and Characterization of Heterocyclic Compounds
- Quinazolinone synthesis and applications
- Cancer Mechanisms and Therapy
- Angiogenesis and VEGF in Cancer
- Protein Kinase Regulation and GTPase Signaling
Which keywords describe Fatma A.F. Ragab's research?
The keywords of their largest research topics: Anticancer Agents, Heterocyclic Compounds, Medicinal Chemistry, Tubulin Inhibitors, Vascular Targeting Agents, Biological Evaluation, Synthesis and Antimicrobial Activity.
- endothelial progenitor cells
- Ras Signaling
- Tumorigenesis
- Toxicology
- Quinazoline
- Indirubin
- Quinoxaline
- Antimicrobial
- Antimicrobial Activity
- Biological Evaluation
- Tubulin Inhibitors
- Heterocyclic Compounds
- Anticancer Agents
- Medicinal Chemistry
- Vascular Targeting Agents
- Synthesis
- Anticancer
- Derivatives
- Drug Discovery
- Pim Oncogenes
- Quinones
- Triazines
- Protein Kinases
- VEGF
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 24 words, with their numbers
- Anticancer Agents203 topics
- Heterocyclic Compounds172 topics
- Medicinal Chemistry172 topics
- Tubulin Inhibitors131 topic
- Vascular Targeting Agents131 topic
- Biological Evaluation103 topics
- Synthesis103 topics
- Antimicrobial Activity72 topics
- Anticancer62 topics
- Antimicrobial62 topics
- Derivatives41 topic
- Quinoxaline41 topic
- Drug Discovery31 topic
- Indirubin31 topic
- Pim Oncogenes31 topic
- Quinazoline31 topic
- Quinones31 topic
- Toxicology31 topic
- Triazines31 topic
- Tumorigenesis31 topic
- Protein Kinases21 topic
- Ras Signaling21 topic
- VEGF21 topic
- endothelial progenitor cells21 topic
Where does Fatma A.F. Ragab work?
Fatma A.F. Ragab's main affiliation in the publication record is Cairo University, Egypt.
How many publications and citations does Fatma A.F. Ragab have?
OpenAlex counts 24 works and 769 citations for Fatma A.F. Ragab, an h-index of 12, ranking #1,562,316 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Fatma A.F. Ragab. Posts are plain text and can be reported.